ArticleCombinatorial chemistry & high throughput screening2025
Comprehensive Bioinformatics Analysis for the Identification of Hub Genes and Critical Signaling Pathways Differentiating Latent and Active Tuberculosis.
Article in Combinatorial chemistry & high throughput screening, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesLatent tuberculosis infection (LTBI) population is the principle source of active tuberculosis (ATB) patients. The identification of reliable diagnostic biomarkers is critical to the prevention and control of progression from LTBI to ATB. The aim of this study is to screen biomarkers that can distinguish LTBI from ATB patients by a comprehensive bioinformatic analysis strategy.
methodsThe transcriptomic datasets were obtained from GEO database. Hub genes and critical signal pathways for differentiating latent and active TB were identified by a comprehensive bioinformatic analysis strategy comprising weighted gene co-expression network analysis (WGCNA), differentially expressed gene (DEG), protein-protein interaction (PPI), Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and hub genes were verified by RT-qPCR in this study.
resultsThe transcriptome profiles of GSE193777, GSE157657, GSE168519, GSE107991, and GSE107992 were extracted from the GEO database, in which a total of 18,397 protein-coding genes from 206 samples were included in the bioinformatics analysis. Combined with weighted gene co-expression network, differentially expressed gene, functional enrichment and proteinprotein interaction analyses, six hub genes were identified. RT-qPCR confirmed significantly lower expression of
conclusionsOur findings may provide crucial clues to potential biomarkers that can distinguish patients with LTBI from those with ATB, aiding the understanding of the mechanism of LTBI progression to ATB.
Indexed as
Identifiers
40444623What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.